8-KThe WireRoutine
Company Update
Filed Apr 15, 2024 · 2y ago · Accession 0001193125-24-095472
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- 8-K
- Filing date
- Apr 15, 2024
- Report date
- Apr 15, 2024
- Document
- d805556d8k.htm
- Size
- 144 KB